To further our mission, we annually award research grants to institutions and medical professionals whose research focuses on cancers that present the greatest opportunities for a homerun cancer cure.
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
The Cure Starts Now has funded $22,574,694 in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 139 grants at over 100 hospitals in 17 countries.
Children's National Medical Center - $200,000
Validation of TAK228 as an effective drug for treating children with DIPG
Ann & Robert H. Lurie Children's Hospital - $100,000
Determine the efficacy of BMP and MEK inhibitors with RT to treat ACVR1 mutant DIPG
Anschutz Medical Campus - $50,000
Toward a Multimodality Cure for DIPG: Investigation of Intratumoral Drug Penetration and Craniospinal Irradiation.
Massachusetts General Hospital - $50,000
Repurposing Mefloquine for Diffuse Intrinsic Pontine Glioma Therapy
CONNECT Consortium - $893,678.37
CONNECT (COllaborative Network for NEurooncology Clinical Trials) Consortium
University of Massachusetts Medical School - $50,000
Advanced RNAi therapeutics for DIPG
Lucile Packard Children's Hospital Stanford - $50,000
Cellular Cybercriminals: DIPG Hacks into the Neural Communication Infrastructure
Hospital for Sick Children - $50,000
MRI Guided Focused Ultrasound: Targeted Drug Delivery in Diffuse Intrinsic Pontine Glioma
Gustave Roussy Cancer Center - $93,071
Ultrasound-induced delivery of Panobinostat in preclinical models
The Hospital for Sick Children - $194,260
Exploring the interactome of H3K27M to find therapeutic targets for DIPG
Cold Spring Harbor Laboratory - $100,000
Allele-specific antisense therapy for DIPG
Children's Cancer Institute - $143,884
Radiosensitisation of Diffuse Intrinsic Pontine Gliomas by modulating the glucose metabolism
Dana-Farber Cancer Institute - $100,000
Characterizing resistance mechanisms to radiation therapy and adjuvant chemotherapy in Diffuse Intrinsic Pontine Glioma
Cincinnati Children's Hospital Medical Center - $100,000
An early Phase 2 Study of LEE011, a CDK4/6 Inhibitor, following radiation therapy in Children with Newly Diagnosed non-biopsied Diffuse Pontine Gliomas (DIPG) and Rb+ biopsied DIPG and High Grade Gliomas (HGG)
Baylor College of Medicine/Texas Children's Hospital - $200,000
Targeting DIPGs through Super-activation of Steroid Receptor Co-activators: An in vivo Study in Patient-derived Intra-brain Stem Xenograft Mouse Models